This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melillo, R. M.
Right arrow Articles by Lax, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melillo, R. M.
Right arrow Articles by Lax, I.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2001, p. 4177-4187, Vol. 21, No. 13
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.13.4177-4187.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling Cascade

R. M. Melillo,1 M. Santoro,1 S.-H. Ong,2 M. Billaud,3 A. Fusco,1 Y. R. Hadari,2 J. Schlessinger,2 and I. Lax2,*

Department of Pharmacology and the Skirball Institute, New York University Medical Center, New York, New York 100162; Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Naples, Italy1; and Laboratoire de Génétique, CNRS UMR5641, Lyon 69373, France3

Received 12 September 2000/Returned for modification 26 October 2000/Accepted 5 April 2001

The receptor tyrosine kinase RET functions as the signal transducing receptor for the GDNF (for "glial cell-derived neurotrophic factors") family of ligands. Mutations in the RET gene were implicated in Hirschsprung disease (HSCR), multiple endocrine neoplasia type 2 (MEN 2), and thyroid carcinomas. In this report we demonstrate that the docking protein FRS2 is tyrosine phosphorylated by ligand-stimulated and by constitutively activated oncogenic forms of RET. Complex formation between RET and FRS2 is mediated by binding of the phosphotyrosine-binding domain of FRS2 to pY1062, a residue in RET that also functions as a binding site for Shc. However, overexpression of FRS2 but not Shc potentiates mitogen-activated protein (MAP) kinase activation by RET oncoproteins. We demonstrate that oncogenic RET-PTC proteins are associated with FRS2 constitutively, leading to tyrosine phosphorylation of FRS2, MAP kinase stimulation, and cell proliferation. However, loss-of-function HSCR-associated RET mutants exhibit impaired FRS2 binding and reduced MAP kinase activation. These experiments demonstrate that FRS2 couples both ligand-regulated and oncogenic forms of RET, with the MAP kinase signaling cascade as part of the response of RET under normal biological conditions and pathological conditions, such as MEN 2 and papillary thyroid carcinomas.

* Corresponding author. Mailing address: Department of Pharmacology and the Skirball Institute, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-2221. Fax: (212) 263-7133. E-mail: laxi01{at}endeavor.med.nyu.edu.

Molecular and Cellular Biology, July 2001, p. 4177-4187, Vol. 21, No. 13
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.13.4177-4187.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sims-Lucas, S., Cullen-McEwen, L., Eswarakumar, V. P., Hains, D., Kish, K., Becknell, B., Zhang, J., Bertram, J. F., Wang, F., Bates, C. M. (2009). Deletion of Frs2{alpha} from the ureteric epithelium causes renal hypoplasia. Am. J. Physiol. Renal Physiol. 297: F1208-F1219 [Abstract] [Full Text]  
  • Castellone, M. D., De Falco, V., Rao, D. M., Bellelli, R., Muthu, M., Basolo, F., Fusco, A., Gutkind, J. S., Santoro, M. (2009). The {beta}-Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation. Cancer Res. 69: 1867-1876 [Abstract] [Full Text]  
  • Mariggio, S., Filippi, B. M., Iurisci, C., Dragani, L. K., De Falco, V., Santoro, M., Corda, D. (2007). Cytosolic Phospholipase A2{alpha} Regulates Cell Growth in RET/PTC-Transformed Thyroid Cells. Cancer Res. 67: 11769-11778 [Abstract] [Full Text]  
  • Riesco-Eizaguirre, G., Santisteban, P. (2007). New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy. Endocr Relat Cancer 14: 957-977 [Abstract] [Full Text]  
  • Kondo, T., Zheng, L., Liu, W., Kurebayashi, J., Asa, S. L., Ezzat, S. (2007). Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression. Cancer Res. 67: 5461-5470 [Abstract] [Full Text]  
  • Santoro, M., Melillo, R. M., Fusco, A. (2006). RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.. Eur J Endocrinol 155: 645-653 [Abstract] [Full Text]  
  • de Groot, J. W. B., Links, T. P., Plukker, J. T. M., Lips, C. J. M., Hofstra, R. M. W. (2006). RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors. Endocr. Rev. 27: 535-560 [Abstract] [Full Text]  
  • Zhang, Y., Zhu, W., Wang, Y.-G., Liu, X.-J., Jiao, L., Liu, X., Zhang, Z.-H., Lu, C.-L., He, C. (2006). Interaction of SH2-B{beta} with RET is involved in signaling of GDNF-induced neurite outgrowth. J. Cell Sci. 119: 1666-1676 [Abstract] [Full Text]  
  • Iavarone, C., Acunzo, M., Carlomagno, F., Catania, A., Melillo, R. M., Carlomagno, S. M., Santoro, M., Chiariello, M. (2006). Activation of the Erk8 Mitogen-activated Protein (MAP) Kinase by RET/PTC3, a Constitutively Active Form of the RET Proto-oncogene. J. Biol. Chem. 281: 10567-10576 [Abstract] [Full Text]  
  • Read, R. D., Goodfellow, P. J., Mardis, E. R., Novak, N., Armstrong, J. R., Cagan, R. L. (2005). A Drosophila Model of Multiple Endocrine Neoplasia Type 2. Genetics 171: 1057-1081 [Abstract] [Full Text]  
  • Fukuda, T., Asai, N., Enomoto, A., Takahashi, M. (2005). Activation of c-Jun amino-terminal kinase by GDNF induces G2/M cell cycle delay linked with actin reorganization. GENES CELLS 10: 655-663 [Abstract] [Full Text]  
  • Scott, R. P., Eketjall, S., Aineskog, H., Ibanez, C. F. (2005). Distinct Turnover of Alternatively Spliced Isoforms of the RET Kinase Receptor Mediated by Differential Recruitment of the Cbl Ubiquitin Ligase. J. Biol. Chem. 280: 13442-13449 [Abstract] [Full Text]  
  • Zhang, Y., Lin, Y., Bowles, C., Wang, F. (2004). Direct Cell Cycle Regulation by the Fibroblast Growth Factor Receptor (FGFR) Kinase through Phosphorylation-dependent Release of Cks1 from FGFR Substrate 2. J. Biol. Chem. 279: 55348-55354 [Abstract] [Full Text]  
  • Schuetz, G., Rosario, M., Grimm, J., Boeckers, T. M., Gundelfinger, E. D., Birchmeier, W. (2004). The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. JCB 167: 945-952 [Abstract] [Full Text]  
  • Fagin, J A (2004). How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J Endocrinol 183: 249-256 [Abstract] [Full Text]  
  • Hwang, E. S., Kim, D. W., Hwang, J. H., Jung, H. S., Suh, J. M., Park, Y. J., Chung, H. K., Song, J. H., Park, K. C., Park, S. H., Yun, H.-J., Kim, J. M., Shong, M. (2004). Regulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT1-Dependent Genes by RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Oncogenic Tyrosine Kinases. Mol. Endocrinol. 18: 2672-2684 [Abstract] [Full Text]  
  • Jijiwa, M., Fukuda, T., Kawai, K., Nakamura, A., Kurokawa, K., Murakumo, Y., Ichihara, M., Takahashi, M. (2004). A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia. Mol. Cell. Biol. 24: 8026-8036 [Abstract] [Full Text]  
  • Drosten, M., Hilken, G., Bockmann, M., Rodicker, F., Mise, N., Cranston, A. N., Dahmen, U., Ponder, B. A. J., Putzer, B. M. (2004). Role of MEN2A-Derived RET in Maintenance and Proliferation of Medullary Thyroid Carcinoma. JNCI J Natl Cancer Inst 96: 1231-1239 [Abstract] [Full Text]  
  • Melillo, R. M., Cirafici, A. M., De Falco, V., Bellantoni, M., Chiappetta, G., Fusco, A., Carlomagno, F., Picascia, A., Tramontano, D., Tallini, G., Santoro, M. (2004). The Oncogenic Activity of RET Point Mutants for Follicular Thyroid Cells May Account for the Occurrence of Papillary Thyroid Carcinoma in Patients Affected by Familial Medullary Thyroid Carcinoma. Am. J. Pathol. 165: 511-521 [Abstract] [Full Text]  
  • Myers, S. M., Mulligan, L. M. (2004). The RET Receptor Is Linked to Stress Response Pathways. Cancer Res. 64: 4453-4463 [Abstract] [Full Text]  
  • Vitagliano, D., Carlomagno, F., Motti, M. L., Viglietto, G., Nikiforov, Y. E., Nikiforova, M. N., Hershman, J. M., Ryan, A. J., Fusco, A., Melillo, R. M., Santoro, M. (2004). Regulation of p27Kip1 Protein Levels Contributes to Mitogenic Effects of the RET/PTC Kinase in Thyroid Carcinoma Cells. Cancer Res. 64: 3823-3829 [Abstract] [Full Text]  
  • Encinas, M., Crowder, R. J., Milbrandt, J., Johnson, E. M. Jr. (2004). Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival. J. Biol. Chem. 279: 18262-18269 [Abstract] [Full Text]  
  • Vasko, V, Saji, M, Hardy, E, Kruhlak, M, Larin, A, Savchenko, V, Miyakawa, M, Isozaki, O, Murakami, H, Tsushima, T, Burman, K D, De Micco, C, Ringel, M D (2004). Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J. Med. Genet. 41: 161-170 [Abstract] [Full Text]  
  • Agazie, Y. M., Hayman, M. J. (2003). Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling. Mol. Cell. Biol. 23: 7875-7886 [Abstract] [Full Text]  
  • Fischer, A. H., Taysavang, P., Jhiang, S. M. (2003). Nuclear Envelope Irregularity Is Induced by RET/PTC During Interphase. Am. J. Pathol. 163: 1091-1100 [Abstract] [Full Text]  
  • Kim, D. W., Hwang, J. H., Suh, J. M., Kim, H., Song, J. H., Hwang, E. S., Hwang, I. Y., Park, K. C., Chung, H. K., Kim, J. M., Park, J., Hemmings, B. A., Shong, M. (2003). RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinomas) Tyrosine Kinase Phosphorylates and Activates Phosphoinositide-Dependent Kinase 1 (PDK1): An Alternative Phosphatidylinositol 3-Kinase-Independent Pathway to Activate PDK1. Mol. Endocrinol. 17: 1382-1394 [Abstract] [Full Text]  
  • Hwang, J. H., Kim, D. W., Suh, J. M., Kim, H., Song, J. H., Hwang, E. S., Park, K. C., Chung, H. K., Kim, J. M., Lee, T.-H., Yu, D.-Y., Shong, M. (2003). Activation of Signal Transducer and Activator of Transcription 3 by Oncogenic RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Tyrosine Kinase: Roles in Specific Gene Regulation and Cellular Transformation. Mol. Endocrinol. 17: 1155-1166 [Abstract] [Full Text]  
  • Pelicci, G., Troglio, F., Bodini, A., Melillo, R. M., Pettirossi, V., Coda, L., De Giuseppe, A., Santoro, M., Pelicci, P. G. (2002). The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway. Mol. Cell. Biol. 22: 7351-7363 [Abstract] [Full Text]  
  • Tsui-Pierchala, B. A., Ahrens, R. C., Crowder, R. J., Milbrandt, J., Johnson, E. M. Jr. (2002). The Long and Short Isoforms of Ret Function as Independent Signaling Complexes. J. Biol. Chem. 277: 34618-34625 [Abstract] [Full Text]  
  • Murakami, H., Yamamura, Y., Shimono, Y., Kawai, K., Kurokawa, K., Takahashi, M. (2002). Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase. J. Biol. Chem. 277: 32781-32790 [Abstract] [Full Text]  
  • Mood, K., Friesel, R., Daar, I. O. (2002). SNT1/FRS2 Mediates Germinal Vesicle Breakdown Induced by an Activated FGF Receptor1 in Xenopus Oocytes. J. Biol. Chem. 277: 33196-33204 [Abstract] [Full Text]  
  • Fusco, A., Chiappetta, G., Hui, P., Garcia-Rostan, G., Golden, L., Kinder, B. K., Dillon, D. A., Giuliano, A., Cirafici, A. M., Santoro, M., Rosai, J., Tallini, G. (2002). Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma : A Search for the Early Precursors of Papillary Cancer. Am. J. Pathol. 160: 2157-2167 [Abstract] [Full Text]  
  • Fukuda, T., Kiuchi, K., Takahashi, M. (2002). Novel Mechanism of Regulation of Rac Activity and Lamellipodia Formation by RET Tyrosine Kinase. J. Biol. Chem. 277: 19114-19121 [Abstract] [Full Text]  
  • Yan, K. S., Kuti, M., Yan, S., Mujtaba, S., Farooq, A., Goldfarb, M. P., Zhou, M.-M. (2002). FRS2 PTB Domain Conformation Regulates Interactions with Divergent Neurotrophic Receptors. J. Biol. Chem. 277: 17088-17094 [Abstract] [Full Text]  
  • Carlomagno, F., Vitagliano, D., Guida, T., Napolitano, M., Vecchio, G., Fusco, A., Gazit, A., Levitzki, A., Santoro, M. (2002). The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes. Cancer Res. 62: 1077-1082 [Abstract] [Full Text]  
  • Basolo, F., Giannini, R., Monaco, C., Melillo, R. M., Carlomagno, F., Pancrazi, M., Salvatore, G., Chiappetta, G., Pacini, F., Elisei, R., Miccoli, P., Pinchera, A., Fusco, A., Santoro, M. (2002). Potent Mitogenicity of the RET/PTC3 Oncogene Correlates with Its Prevalence in Tall-Cell Variant of Papillary Thyroid Carcinoma. Am. J. Pathol. 160: 247-254 [Abstract] [Full Text]  
  • Coulpier, M., Anders, J., Ibanez, C. F. (2002). Coordinated Activation of Autophosphorylation Sites in the RET Receptor Tyrosine Kinase. IMPORTANCE OF TYROSINE 1062 FOR GDNF MEDIATED NEURONAL DIFFERENTIATION AND SURVIVAL. J. Biol. Chem. 277: 1991-1999 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»